Clinical Trial Update: MDMA in Borderline Personality Disorder [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial sponsored by Yale University evaluating MDMA for Borderline Personality Disorder is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Borderline Personality Disorder

Drugs mentioned

• MDMA (3,4-methylenedioxymethamphetamine)

Snippet

Sponsor: Yale University | Conditions: Borderline Personality Disorder | Phase 2 | Status: RECRUITING